LOADING
Comparing Tesla Inc (TSLA) and Merck & Company (MRK) across the Consumer Discretionary and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TSLA | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.48T | $286.6B |
| P/E Ratio | 372.6 | 15.9 |
| Forward P/E | 200.0 | 22.6 |
| PEG Ratio | 5.71 | 3.54 |
| EPS | $1.06 | $7.27 |
| Revenue Growth (YoY) | -3.1% | 5.0% |
| Profit Margin | 4.0% | 28.1% |
| Return on Equity | 4.9% | 36.9% |
| Dividend Yield | -- | 2.79% |
| Beta | 1.93 | 0.26 |
| 52-Week High | $498.83 | $125.14 |
| 52-Week Low | $214.25 | $71.26 |
| Volume | -- | -- |
Tesla Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.